Intracerebral inflammation after human brain contusion

Neurosurgery

Volumn 42, Issue 2, 1998, Pages 291-299

  Holmin, Staffan ^a   Söderlund, Johan ^a   Biberfeld, Peter ^a   Mathiesen, Tut ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoimmunity; Inflammation; Leukocytes; Microglia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; BRAIN CONTUSION; CELL INFILTRATION; ENCEPHALITIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; NERVE CELL DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIGEN-PRESENTING CELLS; BIOPSY; BRAIN; BRAIN CONCUSSION; CHILD; ENCEPHALITIS; FEMALE; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; MALE; MIDDLE AGED;

EID: 0344074656     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199802000-00047     Document Type: Article

References (62)

1. Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MM, Hofman A: Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 45:1441-1445, 1995.
2. Bahal N, Nahata MC: The role of corticosteroids in infants and children with bacterial meningitis. DICP 25:542-545, 1991.
3. Braakman R, Schouten HJ, Blaauw-van Dishoeck M, Minderhoud JM: Megadose steroids in severe head injury: Results of a prospective double-blind clinical trial. J Neurosurg 58:326-330, 1983.
4. Breitner JC: Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: A current appraisal. Neurobiol Aging 17:789-794, 1996.
5. Breitner JC, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD, Pericak-Vance MA, Saunders AM: Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging 16:523-530, 1995.
6. Brugg B, Dubreuil YL, Huber G, Wollman EE, Delhaye-Bouchaud N, Mariani J: Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc Natl Acad Sci U S A 92:3032-3035, 1995.
7. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC: Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 27:431-441, 1997.
8. Coria F, Rubio I, Bayon C: Alzheimer's disease, beta-amyloidosis, and aging. Rev Neurosci 5:275-292, 1994.
9. Donnelly RJ, Friedhoff AJ, Beer B, Blume AJ, Vitek MP: Interleukin-1 stimulates the beta-amyloid precursor protein promoter. Cell Mol Neurobiol 10:485-495, 1990.
10. Du Plessis JJ: High-dose dexamethasone therapy in head injury: A patient group that may benefit from therapy. Br J Neurosurg 6:145-147, 1992.
11. Fishman RA: Brain edema. N Engl J Med 293:706-711, 1975.
12. Frei K Piani D, Pfister HW, Fontana A: Immune-mediated injury in bacterial meningitis. Int Rev Exp Pathol 34:183-192, 1993.
13. Gedye A, Beattie BL, Tuokko H, Horton A, Korsarek E: Severe head injury hastens age of onset of Alzheimer's disease. J Am Geriatr Soc 37:970-973, 1989.
14. Goldgaber D, Harris HW, Hla T, Maciag T, Donnelly RJ, Jacobsen JS, Vitek MP, Gajdusek DC: Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci U S A 86:7606-7610, 1989.
15. Goodman JC, Robertson CS, Grossman RG, Narayan RK: Elevation of tumor necrosis factor in head injury. J Neuroimmunol 30:213-217, 1990.
16. Graves AB, White E, Koepsell TD, Reifler BV, van Belle G, Larson EB Raskind M: The association between head trauma and Alzheimer's disease. Am J Epidemiol 131:491-501, 1990.
17. Gray CW, Patel AJ: Regulation of beta-amyloid precursor protein isoform mRNAs by transforming growth factor-beta 1 and interleukin-1 beta in astrocytes. Brain Res Mol Brain Res 19:251-256, 1993.
18. Griffin WS, Sheng JG, Gentleman SM, Graham DI, Mrak RE, Roberts GW: Microglial interleukin-1 alpha expression in human head injury: Correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci Lett 176:133-136, 1994.
19. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL III, Araoz C: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 86:7611-7615, 1989.
20. Hartung HP, Archelos JJ, Zielasek J, Gold R, Koltzenburg M, Reiners KH, Toyka KV: Circulating adhesion molecules and inflammatory mediators in demyelination: A review. Neurology 45[Suppl 6]:S22-S32, 1995.
21. Hartwig M: Immune ageing and Alzheimer's disease. Neuroreport 6:1274-1276, 1995.
22. Deleted in proof.
23. Holmin S, Mathiesen T: Biphasic edema development after experimental brain contusion in rat. Neurosci Lett 194:97-100, 1995.
24. Holmin S, Mathiesen T: Dexamethasone and colchicine reduce inflammation and delayed edema following experimental brain contusion. Acta Neurochir 138:418-424, 1996.
25. Deleted in proof.
26. Holmin S, Mathiesen T, Shetye J, Biberfeld P: Intracerebral inflammatory response to experimental brain contusion. Acta Neurochir 132:110-119, 1995.
27. Holmin S, Schalling M, Hojeberg B, Nordqvist AC, Skeftruna AK, Mathiesen T: Delayed cytokine expression in rat brain following experimental contusion. J Neurosurg 86:493-504, 1997.
28. Hopkins SJ, Rothwell NJ: Cytokines and the nervous system: I - Expression and recognition. Trends Neurosci 18:83-88, 1995.
29. Huberman M, Shalit F, Roth-Deri I, Gutman B, Brodie C, Kott E, Sredni B: Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage. J Neuroimmunol 52:147-152, 1994.
30. Jennet B, Teasdale G: Management of head injuries: Philadelphia, F.A. Davis, 1981, pp 71-93.
31. Kawamata T, Akiyama H, Yamada T, McGeer PL: Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 140:691-707, 1992.
32. Lebel MH, Freij BJ, Syrogiannopoulos GA, Chrane DF, Hoyt MJ, Stewart SM, Kennard BD, Olsen KD, McCracken GH Jr: Dexamethasone therapy for bacterial meningitis: Results of two double-blind, placebo-controlled trials. N Engl J Med 319:964-971, 1988.
33. Logan A, Berry M: Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS. Trends Pharmacol Sei 14:337-342, 1993.
34. Marks MI: Bacterial meningitis: An update. Clin Pediatr (Phila) 30:673-675, 1991.
35. Mathiesen T, Kakarieka A, Edner G: Traumatic intracerebral lesions without extracerebral haematoma in 218 patients. Acta Neurochir 137:155-163, 1995.
36. McClain CJ, Cohen D, Ott L, Dinarello CA, Young B: Ventricular fluid interleukin-1 activity in patients with head injury. J Lab Clin Med 110:48-54, 1987.
37. McGeer PL, McGeer E, Rogers J, Sibley J: Anti-inflammatory drugs and Alzheimer disease. Lancet 335:1037, 1990 (letter).
38. McGeer PL, McGeer EG: The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21:195-218, 1995.
39. McKenzie JE, Gentleman SM, Roberts GW, Graham DI, Royston MC: Increased numbers of beta APP-immunoreactive neurones in the entorhinal cortex after head injury. Neuroreport 6:161-164, 1994.
40. McLaurin RL, Helmer F: The syndrome of temporal-lobe contusion. J Neurosurg 23:296-304, 1965.
41. Mitrovic B, Ignarro LJ, Montestruque S, Smoll A, Merrill JE: Nitric oxide as a potential pathological mechanism in demyelination: Its differential effects on primary glial cells in vitro. Neuroscience 61:575-585, 1994.
42. Myllykangas-Luosujarvi R, Isomaki H: Alzheimer's disease and rheumatoid arthritis. Br J Rheumatol 33:501-502, 1994 (letter).
43. Olsson T: Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 144:245-268, 1995.
44. Palluy O, Rigaud M: Nitric oxide induces cultured cortical neuron apoptosis. Neurosci Lett 208:1-4, 1996.
45. Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J: Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45:51-55, 1995.
46. Roberts GW, Allsop D, Bruton C: The occult aftermath of boxing. J Neurol Neurosurg Psychiatry 53:373-378, 1990.
47. Roberts GW, Gentleman SM, Lynch A, Graham DI: Beta A4 amyloid protein deposition in brain after head trauma. Lancet 338:1422-1423, 1991.
48. Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI: Beta amyloid protein deposition in the brain after severe head injury: Implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 57:419-425, 1994.
49. Ross SA, Halliday MI, Campbell GC, Byrnes DP, Rowlands BJ: The presence of tumour necrosis factor in CSF and plasma after severe head injury. Br J Neurosurg 8:419-425, 1994.
50. Rothwell NJ, Hopkins SJ: Cytokines and the nervous system: II - Actions and mechanisms of action. Trends Neurosci 18:130-136, 1995.
51. Royston MC, Rothwell NJ, Roberts GW: Alzheimer's disease: Pathology to potential treatments? Trends Pharmacol Sci 13:131-133, 1992.
52. Schoettle RJ, Kochanek PM, Magargee MJ, UhI MW, Nemoto EM: Early polymorphonuclear leukocyte accumulation correlates with the development of posttraumatic cerebral edema in rats. J Neurotrauma 7:207-217, 1990.
53. Soares HD, Hicks RK, Smith D, McIntosh TK: Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci 15:8223-8233, 1995.
54. Statham PF, Johnston RA, Macpherson P: Delayed deterioration in patients with traumatic frontal contusions. J Neurol Neurosurg Psychiatry 52:351-354, 1989.
55. Stein SC, Spettell C, Young G, Ross SE: Delayed and progressive brain injury in closed-head trauma: Radiological demonstration. Neurosurgery 32:25-31, 1993.
56. St. George-Hyslop PH, Haines JL, Farrer LA, Polinsky R, Van Broeckhoven C, Goate A, McLachlan DR, Orr H, Bruni AC, Sorbi S: Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder: FAD Collaborative Study Group. Nature 347:194-197, 1990.
57. Strauss S, Bauer J, Ganter U, Jonas U, Berger M, Volk B: Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 66:223-230, 1992.
58. Toulmond S, Rothwell NJ: Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res 671:261-266, 1995.
59. Ulvestad E, Williams K, Bjerkvig R, Tiekotter K, Antel J, Matre R: Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J Leukoc Biol 56:732-740, 1994.
60. Ulvestad E, Williams K, Bo L, Trapp B, Antel J, Mork S: HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro. Immunology 82:535-541, 1994.
61. Unterberg A, Kiening K, Schmiedek P, Lanksch W: Long-term observations of intracranial pressure after severe head injury: The phenomenon of secondary rise of intracranial pressure. Neurosurgery 32:17-24, 1993.
62. Wucherpfennig KW: Autoimmunity in the central nervous system: mechanisms of antigen presentation and recognition. Clin Immunol Immunopathol 72:293-306, 1994.